Holen Sie sich die Stockscreener-App
30.28
0.53%
-0.16
Schlusskurs vom Vortag:
$30.44
Offen:
$30.34
24-Stunden-Volumen:
881.23K
Relative Volume:
1.37
Marktkapitalisierung:
$3.74B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.95%
1M Leistung:
-24.51%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$28.30
$30.63
1-Wochen-Bereich:
$28.30
$33.76
52-Wochen-Spanne:
$24.51
$42.48
Parabilis Medicines Inc Stock (PBLS) Company Profile
Firmenname
Parabilis Medicines Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare PBLS vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBLS
Parabilis Medicines Inc
|
30.28 | 3.85B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Parabilis Medicines Inc Aktie (PBLS) Neueste Nachrichten
Top Parabilis Medicines (PBLS) Competitors 2026 - MarketBeat
Parabilis Medicines (NASDAQ:PBLS) Shares Gap UpTime to Buy? - MarketBeat
Parabilis Medicines, Inc. (PBLS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Parabilis Medicines (NASDAQ:PBLS) Shares Up 6%What's Next? - MarketBeat
Sixty Degree Capital Extends Its Track Record as Five Portfolio Companies Enter the Public Markets in 2026 - Moomoo
Parabilis Medicines (PBLS) Stock Price, News & Analysis - Stock Titan
PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 6.3%What's Next? - MarketBeat
Parabilis Medicines (Nasdaq:PBLS)Stock Analysis - Simply Wall Street
Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to S&P TMI Index - marketscreener.com
Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Biotech Stocks At 52-Week HighsMNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO - RTTNews
Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to Russell 3000 Growth Benchmark - marketscreener.com
Parabilis Medicines (NASDAQ:PBLS) Hits New 52-Week HighTime to Buy? - MarketBeat
BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $45 - moomoo.com
48,484 Shares in Parabilis Medicines, Inc. $PBLS Acquired by Squarepoint Ops LLC - MarketBeat
PBLS: Zolucatetide advances as a multi-indication therapy, with strong data and broad pipeline expansion - TradingView
Parabilis at Morgan Stanley conference: broad bet on beta-catenin - Investing.com
PBLS: Zolucatetide's clinical progress and platform innovation drive a broad pipeline and major upcoming milestones - TradingView
Parabilis Medicines (NASDAQ:PBLS) Trading Up 6%Still a Buy? - MarketBeat
Parabilis Medicines to Showcase Updated Zolucatetide Trial Results at ESMO 2026 - Kalkine Media
WINTON GROUP Ltd Takes Position in Parabilis Medicines, Inc. $PBLS - marketbeat.com
Parabilis Medicines (PBLS) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
1,920,805 Shares in Parabilis Medicines, Inc. $PBLS Purchased by Frazier Life Sciences Management L.P. - MarketBeat
Parabilis Medicines, Inc. Common Stock (NASDAQ: PBLS) Stock Price, News & Analysis - Kalkine
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewswire
ICONIQ Capital LLC Takes $9.58 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat
Regeneron Pharmaceuticals Inc. Buys New Stake in Parabilis Medicines, Inc. $PBLS - MarketBeat
1,600,937 Shares in Parabilis Medicines, Inc. $PBLS Purchased by General Catalyst Group Management LLC - MarketBeat
venBio Partners LLC Takes $144.15 Million Position in Parabilis Medicines, Inc. $PBLS - MarketBeat
Jupiter Topco LLC Buys Shares of 2,296,547 Parabilis Medicines, Inc. $PBLS - MarketBeat
Parabilis Medicines, Inc. (NASDAQ:PBLS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Parabilis appoints Craig Tendler to its Board and Science & Technology Committee - TradingView
Parabilis Medicines adds former J&J oncology executive to board By Investing.com - Investing.com Canada
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors - Yahoo Finance
ICONIQ Capital LLC Makes New Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat
Parabilis Medicines Price Insights - YCharts
Parabilis Medicines (NASDAQ:PBLS) Stock Price Up 5.9%Here's What Happened - MarketBeat
Alphabet Inc. Makes New $134.65 Million Investment in Parabilis Medicines, Inc. $PBLS - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Biotech’s reverse merger renaissance poised to continue - Endpoints News
Parabilis Medicines (NASDAQ:PBLS) Sets New 1-Year HighWhat's Next? - MarketBeat
Focus Partners Advisor Solutions LLC Invests $1.35 Million in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS) - The Globe and Mail
Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News - Moomoo
Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership - Stock Titan
BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating - Moomoo
Parabilis Medicines: A Rare-Tumor Validation Ladder For An Undruggable Platform (NASDAQ:PBLS) - Seeking Alpha
Parabilis Medicines (NasdaqGS:PBLS) Stock Forecast & Analyst Predictions - Simply Wall Street
PBLS SWOT Analysis: Financial Resilience Amidst Clinical Challen - GuruFocus
Finanzdaten der Parabilis Medicines Inc-Aktie (PBLS)
Es liegen keine Finanzdaten für Parabilis Medicines Inc (PBLS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Parabilis Medicines Inc-Aktie (PBLS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jul 21 '26 |
Buy |
29.25 |
65,923 |
1,928,032 |
26,482,436 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jul 22 '26 |
Buy |
29.77 |
47,250 |
1,406,632 |
26,529,686 |
| Levy Guy | 10% Owner |
Jun 11 '26 |
Buy |
20.00 |
500,000 |
10,000,000 |
1,027,000 |
| SEBULSKY ALAN | Director |
Jun 15 '26 |
Buy |
26.49 |
9,065 |
240,135 |
30,000 |
| SEBULSKY ALAN | Director |
Jun 12 '26 |
Buy |
27.67 |
8,435 |
233,393 |
20,935 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 11 '26 |
Buy |
20.00 |
21,188,750 |
423,775,000 |
26,285,093 |
| SEBULSKY ALAN | Director |
Jun 11 '26 |
Buy |
20.00 |
12,500 |
250,000 |
12,500 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):